| Address |
2 Queen Street East Suite 1500 Toronto, M5C 3G5 Canada |
|
| Address type | Registered Office Address | |
| Address province | Ontario |
| Corporation ID | 9224793 | |
| Business number | 806657789 | |
| Status | Active | |
| ACT | Canada Business Corporations Act | |
| Anniversary date | 03/18/2015 | |
| Last annual filing | 2026 | |
| Data verified | 10/31/2026 |
Location: Statistics Canada, Open Database of Addresses (Open Government Licence – Canada).
| Name | Effective date | Type | Current |
|---|---|---|---|
| Qing Bile Therapeutics Inc. | 03/18/2015 | Corporate Name | true |
last updated: 2026-10-30
1 federal grant and contribution in 2018 with a total value of $29,801.
| Start date | Department and program | Value |
|---|---|---|
| 04/02/2018 |
National Research Council Canada Industrial Research Assistance Program – Contributions to Firms (contribution) Evaluation of Cytotoxicity and Effects on Gene Regulation of Selected Bile Acids in a Hepatocyte Model Selected compounds are being developed, for use in treatment of selected metabolic disorders. Nucleic acids extracted from cultured human liver cells will be analyzed to identify changes in the transcriptome in response to treatment with selected compounds. |
$29,801 |
Source: Government of Canada, proactive disclosure of grants and contributions. Contains information licensed under the Open Government Licence – Canada.
| Date | Type | Section |
|---|---|---|
| 08/25/2016 | Amendment | 6 |
| 07/14/2015 | Amendment | 6 |
| 05/06/2015 | Amendment | 6 |
| 03/18/2015 | Incorporation |
| Meeting date | Type of corporation | Year of filing |
|---|---|---|
| 10/30/2016 | Non-distributing corporation with 50 or fewer shareholders | 2017 |
| 10/30/2015 | Non-distributing corporation with 50 or fewer shareholders | 2016 |